JHFA Health Food Certification for Taiwan Supplement Exporters

Japan has three main functional food designation systems for products claiming health benefits. Foods for Specified Health Use (FOSHU) are approved by the Consumer Affairs Agency (CAA) following clinical evidence review. The approval process takes 12 to 24 months and costs approximately JPY 1 to 3 million in testing and application fees. FOSHU allows product-specific health claims such as 'helps reduce blood pressure' but requires clinical evidence specific to the final product formulation.

Foods with Function Claims (FFC), introduced in 2015, allow health claims based on published scientific literature without prior government approval. The seller notifies the CAA with a submission containing the functional claim, supporting evidence, safety information, and manufacturing quality management data. FFC registration takes approximately 60 days from notification acceptance. Over 7,000 FFC products have been registered in Japan as of 2024.

Japan Health Food Association (JHFA) certification is a third-party private quality and safety certification. JHFA does not grant government approval for health claims but certifies that products meet rigorous quality standards: ingredient purity, accurate labelling, and manufacturing quality management. The JHFA mark has high consumer recognition in Japan's health food market and is frequently a condition for specialty retail placement.

For Taiwan supplement exporters, the right pathway depends on market positioning. If you want specific health claims on the Japanese label, FOSHU or FFC registration is necessary. JHFA certification can be pursued independently as a quality signal. Many Taiwan brands pursue JHFA certification first (faster, lower cost) while initiating FFC notification for health claims in parallel.

JHFA certification is available for dietary supplement products including vitamins, minerals, amino acids, herbal extracts, probiotics, and functional food products meeting JHFA's category specifications. Products must be manufactured under a GMP-equivalent quality management system, accurately label all ingredients with quantities, and not contain prohibited substances or undisclosed pharmaceutical ingredients.

JHFA's eligible category list covers approximately 400 ingredient categories with specific purity standards. Key categories for Taiwan exporters: collagen peptides (minimum 90% content), coenzyme Q10 (minimum 98% purity by HPLC), vitamin C (minimum 99% ascorbic acid), probiotics (minimum viable count at end of shelf life), and glucosamine (minimum 98% content). Taiwan manufacturers must verify their specific formulation against JHFA's current specification list before initiating certification.

The manufacturer of the finished product must hold JHFA-registered manufacturing facility status, which requires a separate document review by JHFA auditors. Taiwan manufacturers must apply for facility registration in addition to product certification. Facility registration fees typically range from JPY 100,000 to 300,000 (approximately USD 700 to 2,100).

Japanese importers and distributors can also apply for JHFA certification on behalf of a Taiwan manufacturer if the importer holds a pharmaceutical manufacturing license (seizo hanbai gyosha) in Japan and takes regulatory responsibility for the product. This arrangement is common for Taiwan brands entering Japan through a trading company partner.

The JHFA certification application requires submitting to JHFA headquarters in Tokyo: product specifications listing all ingredients and quantities, a Certificate of Analysis from the production batch, a GMP certificate or equivalent quality management documentation, product label drafts for review, and the manufacturing facility's quality management manual. Applications must be submitted in Japanese, requiring translation services or a Japanese regulatory agent.

Third-party testing by a JHFA-registered testing laboratory is mandatory. Testing verifies active ingredient purity and content, absence of prohibited substances (heavy metals, microbial contamination, banned pharmaceutical compounds), and compliance with JHFA's ingredient-specific standards. Testing costs vary from JPY 100,000 to 500,000 (approximately USD 700 to 3,500) per product depending on complexity.

JHFA review typically takes 3 to 6 months from complete application submission. Common causes of delays for Taiwan exporters: missing Japanese-language translations of manufacturing documentation, disagreement between declared ingredient quantities and test results, or manufacturing facility not meeting JHFA GMP equivalence standards. Engage a Japanese regulatory consultant (cost approximately JPY 300,000 to 800,000) to manage the application.

Certification is valid for 3 years and requires annual surveillance testing to maintain. Annual maintenance fees are approximately JPY 50,000 to 150,000 per product. The JHFA certified product list is publicly searchable on the JHFA website and is actively monitored by Japanese retailers and distributors evaluating suppliers.

JHFA certification alone does not grant the right to make health claims on the product label. Health claims in Japan require FOSHU approval or FFC notification under the CAA's framework. What JHFA certification permits is display of the JHFA mark on product packaging and marketing materials, along with a statement that the product is certified by the Japan Health Food Association as meeting quality standards.

The commercial value of the JHFA mark is substantial in Japan's USD 18 billion health food market. Japanese consumers rate independent certification marks as one of the top 3 factors in health supplement purchase decisions. Japanese specialty retailers frequently feature JHFA-certified products prominently, and JHFA-certified status is a filterable attribute on Amazon Japan and Rakuten.

For Taiwan brands distributing through Japanese trading companies, JHFA certification significantly strengthens distributor recruitment conversations. Japanese trading companies distributing health food products are risk-sensitive due to Japan's pharmaceutical advertising regulations. JHFA certification provides a formal quality guarantee that reduces the trading company's risk exposure.

Combining JHFA certification with FFC notification is the recommended approach for Taiwan supplement brands with clinical evidence. Register JHFA first (3 to 6 months), then file FFC notification with the CAA (60 days from acceptance). Once both are in place, your product can carry the JHFA mark and a permitted health claim, creating a compelling differentiation package for Japanese retail buyers.